VERXVertex Inc - Ordinary Shares Class A
VERX
Vertex Inc - Ordinary Shares Class A453
Mkt Cap
$2.11BVolume
350,623.0052W High
$42.4452W Low
$10.59PE Ratio
-324.38VERX Fundamentals
Price
$13.40Prev Close
$13.17Open
$13.4150D MA
$12.60Beta
0.84Avg. Volume
1.1MEPS (Annual)
$0.0444P/B
8.60Rev/Employee
$356,401.91$3,256.04
Compared to Estimates, Vertex (VERX) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Vertex (VERX) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Vertex (VERX) Tops Q1 Earnings and Revenue Estimates
Vertex (VERX) delivered earnings and revenue surprises of +5.13% and +1.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Biotech Stocks To Add to Your Watchlist - May 6th
Danaher, Avalo Therapeutics, Vertex Pharmaceuticals, United Therapeutics, argenex, ImmunityBio, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that use biological science and technology t...
QRG Capital Management Inc. Increases Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
QRG Capital Management Inc. increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 16.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 18,396 shares of the pharmaceutical company's stock after...
Principal Financial Group Inc. Boosts Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Principal Financial Group Inc. increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 415,100 s...
M&T Bank Corp Increases Holdings in Vertex Pharmaceuticals Incorporated $VRTX
M&T Bank Corp boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 19.5% during the fourth quarter, according to the company in its most recent filing...
Vertex Pharmaceuticals (NASDAQ:VRTX) Director Sangeeta Bhatia Sells 318 Shares
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) Director Sangeeta Bhatia sold 318 shares of the business's stock in a transaction on Monday, May 4th. The stock was sold at an average price of $423.73, for a total value of $134,746.14. Following the completion of the transaction...
Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Sells $469,222.08 in Stock
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) EVP Joy Liu sold 1,104 shares of the company's stock in a transaction dated Friday, May 1st. The shares were sold at an average...
Promising Biotech Stocks To Watch Today - May 5th
Vertex Pharmaceuticals, Danaher, and Viridian Therapeutics are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop and commercialize biological products and technologiessuch as novel drugs, gene thera...
Top Pharmaceutical Stocks To Research - May 5th
Eli Lilly and Company, Cytokinetics, Pfizer, Abbott Laboratories, and Vertex Pharmaceuticals are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, or distri...
<
1
2
...
>
Compact View
Not available
Not available